25 October, 2018

Cataluña allocates 9.5 million to Peris, its health innovation plan

Source: The government has approved this Tuesday for 9.550.000 euros to attend the 2019 call for grants of the Strategic Plan for Research and Innovation […]
23 October, 2018

New advances in the treatment of head and neck tumors

Source: Immunotherapy with pembrolizumab improves survival in patients with head and neck cancer that has recurred or metastasized according to the most recent results of […]
19 October, 2018

Gilead increases its commitment to research in Spain targeting HIV

Source: The biopharmaceutical company Gilead Sciences continues its commitment to research in our country, this time, developing a project to achieve the cure of HIV. […]
18 October, 2018

Breast cancer: the industry leads the research of 169 new drugs

Source: Currently, the pharmaceutical industry has a total of 169 new drugs against breast cancer in the clinical research phase, a disease that encompasses the […]
16 October, 2018

Success of the first trial of Opsumit (Actelion) in portopulmonary hypertension

Source: Actelion Pharmaceuticals has announced the results of the first randomized controlled trial in portopulmonary hypertension (HTPP). This study has shown that Opsumit (macitentan) significantly […]
10 October, 2018

Europe approves Verzenios, from Lilly, for the treatment of advanced breast cancer

Source: The European Commission has authorized the commercialization of Verzenios (abemaciclib), from the pharmaceutical company Lilly, as a treatment of locally advanced or metastatic breast […]
8 October, 2018

Genetic mutations also alter the nature of clinical trials

Source: New ways of researching and developing drugs, in their most advanced oncological aspects, urge health administrations, hospitals, patients and their organizations, Research Ethics Committees […]
5 October, 2018

VHIO develops a precision immunotherapy for breast cancer

Source: Researchers at the Vall d’Hebron Institute of Oncology (VHIO) in Barcelona have achieved that immunotherapy attacks only the tumor cells of a type of […]
3 October, 2018

Nobel Prize for Medicine 2018 for cancer immunotherapy

Source: IntraMed The American James Allison and the Japanese Tasuku Honjo have won the Nobel Prize for Medicine 2018. The jury of the Karolinska Institute in […]
26 September, 2018

EMA gives a positive opinion to Gilenya, from Novartis, for minors with multiple sclerosis

Source: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of the drug Gilenya (fingolimod), […]
21 September, 2018

ISCIII will represent Spain in the largest research appointment in Europe

Source: The director of the Health Institute Carlos III (ISCIII), Raquel Yotti Álvarez, in charge of the head of the Spanish delegation at the opening […]
18 September, 2018

Lilly Foundation awards a study of protein kinase in liver disease

Source: Within the framework of the 41st Annual Congress of the Spanish Society of Biochemistry and Molecular Biology (SEBBM), which is being held in Santander, […]
13 September, 2018

AstraZeneca Foundation encourages young talent with 80,000 euros

Source: The AstraZeneca Foundation, in collaboration with the Carlos III Health Institute, has announced the winners of the IV Young Researchers Awards, a recognition that […]
14 March, 2018

Clinical Trials Area of the Hospital Pharmacy Service

Distefar, considera que las funciones que se llevan a cabo en el servicio de farmacia hospitalaria, dentro del entorno de un estudio con medicamentos, son fundamentales […]
18 February, 2022

High intratumoural heterogeneity of endometrial cancer revealed

Source: Spanish researchers have just published a study that unravels the high intratumoural heterogeneity present in the different subtypes of endometrial cancer (serous and endometrioid) […]
14 February, 2022

CNIO, scientific leadership in oncology research

Source: It is among the top 10 cancer research centres in the world and among the top two in Europe. Since its creation in 1998, […]
9 February, 2022

The new European harmonization of clinical trials, an opportunity to attract more investment to Spain

Since yesterday, the new Clinical Trials Information System (CTIS) has been operational, which centralizes processes with the aim of speeding up these studies Our country starts […]
3 February, 2022

Spain can benefit from the new European harmonization of clinical trials

The new Clinical Trials Information System (CTIS), which centralizes processes with the aim of speeding up these studies, is now operational Source: With the entry […]
24 January, 2022

Seven out of ten drugs in clinical development are ‘first in class’.

A report on the research pipeline of global pharmaceutical companies highlights the importance of this ‘first-in-class’ share for patients with unmet medical needs. It captures notable […]
13 December, 2021

“The pandemic has shown that more Autonomous Communities can host clinical trials of drugs, which is hopeful for many patients”

More than 50% of the trials with new treatments are currently concentrated in Madrid and Barcelona Spain, a benchmark in clinical research, should also bet on […]
17 November, 2021

The AEMPS publishes the memorandum of ethics committees for drug research

Source: The Spanish Agency for Medicines and Health Products (AEMPS) has published the ‘Memorandum of collaboration between the ethics committees of research with medicines (CEIm) […]
4 November, 2021

The MD Anderson Cancer Center in Madrid inaugurates one of the largest Phase I Clinical Trials units in Europe

Source: The foundation works to eradicate cancer worldwide through clinical research, teaching and information to the population This Wednesday, November 3, MD Anderson Cancer Center […]
21 June, 2021

Farmaindustria estimates the investment in 2020 of pharmaceutical companies in research at 39,000 million

Source: Farmaindustria, the employers’ association of the innovative pharmaceutical industry in Spain, has highlighted the role of this sector in Europe “as one of the […]
8 June, 2021

The medicine, health, social and economic value

Biomedical innovation cannot be considered an expense, but rather an investment that redounds in the medium and long term in health systems and in society as […]
21 May, 2021

The investment of the pharmaceutical industry in R&D grows in 2020 despite the pandemic

Via: The pharmaceutical industry investment in R&D has increased during 2020 despite the coronavirus pandemic, but the productivity of clinical trials remains below average. This […]
20 May, 2021

Spain, a country of reference in conducting clinical trials

Via: Clinical trials mobilize financial resources, allow health professionals to add research experience to their care activity and provide patients with early access to new […]